Downloads
Press Releases

DocumentsDate Added

Order by : Name | Date | Hits [ Ascendant ]
The 1st International Optical Coherence Tomography User Meeting was held during the EADV Congress in Lisbon and chaired by Prof Julia Welzel, Dept of Dermatology, Augsburg, Germany. Hosted by Michelson Diagnostics, the meeting brought together a group of leading clinicians from Dermatology and Rheumatology to share their recent clinical experience using OCT.
The funds will be used to expand sales support infrastructure in USA and Europe to respond to growing demand for Michelson’s revolutionary unique laser scanning technology, which can image skin and other surface tissue at a much higher resolution than ever before.
A revolutionary new imaging device that can detect skin cancer like no other technology -- the VivoSight® Optical Coherence Tomography (OCT) scanner -- is now available to dermatologists in the U.S. for the first time.
The University of Leeds' Musculoskeletal Biomedical Research Group publishes research demonstrating the potential of VivoSight to assess psoriatic nail disease.
Michelson Diagnostics announced plans to expand availability of their revolutionary products for skin cancer imaging in the United States.
A presentation by the Dermatology Departments at Roskilde Gentofte Hospitals, Copenhagen  has been awarded gold by the 22nd World Congress of Dermatology.
A case study documenting the successful use of Michelson Diagnostics’ VivoSight OCT scanner for in vivo mapping of non-melanoma skin cancer has been published.
Dr Stephen Matcher, Senior Lecturer in Biomedical Engineering at the Department of Materials Science and Engineering at the University of Sheffield, has been seconded to Michelson Diagnostics
A second investment of £300k into Michelson Diagnostics has been made by Octopus Investments.
Skin cancer imaging firm Michelson Diagnostics Ltd has recruited Patrick Finnemore as Sales & Marketing Manager, UK & Europe.
page 1 of 7
Banner